NCT04034784View on ClinicalTrials.gov

Discrete(TM) Safety Clinical Trial GLAD-01

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

June 18, 2020

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
Safety and Tolerability in Healthy Volunteers
Interventions
DEVICE

Discrete(TM)

A designated volume of Discrete(TM) (according to cohort) is applied intraperitoneally

OTHER

Control Lactated Ringer's Solution (Control LRS)

A designated volume of LRS (according to cohort and equivalent to volume of Discrete(TM)) is applied intraperitoneally

Trial Locations (1)

Unknown

Clinical trial site, Toronto

Sponsors

Lead Sponsor

ARC Medical Inc.
All Listed Sponsors
lead

ARC Medical Inc.

INDUSTRY